JOINTOWN PHARMACEUTICAL GROUP
JOINTOWN PHARMACEUTICAL GROUP, a leading player in the pharmaceutical industry, is headquartered in China and operates extensively across various regions. Founded in 1995, the company has established itself as a key provider of high-quality pharmaceutical products and services, focusing on areas such as drug distribution, manufacturing, and research and development. With a diverse portfolio that includes prescription medications, over-the-counter products, and healthcare services, JOINTOWN is recognised for its commitment to innovation and quality. The company has achieved significant milestones, including strategic partnerships and expansions that enhance its market position. JOINTOWN PHARMACEUTICAL GROUP continues to set industry standards, making it a trusted name in healthcare solutions.
DitchCarbon Score
How does JOINTOWN PHARMACEUTICAL GROUP's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
JOINTOWN PHARMACEUTICAL GROUP's score of 7 is lower than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
JOINTOWN PHARMACEUTICAL GROUP's reported carbon emissions
In 2023, JOINTOWN PHARMACEUTICAL GROUP reported total carbon emissions of approximately 318,939,120 kg CO2e, all of which fall under Scope 1 emissions. This includes emissions from mobile combustion, accounting for about 2,405,420 kg CO2e, and stationary combustion, which contributed approximately 4,334,300 kg CO2e. Currently, JOINTOWN PHARMACEUTICAL GROUP has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. As a result, their climate commitments remain unclear, and there are no documented pledges or targets aligned with industry standards such as the Science Based Targets initiative (SBTi). The company operates within a sector increasingly focused on sustainability, and it will be essential for them to establish clear climate commitments to align with global efforts to mitigate climate change.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | |
|---|---|
| Scope 1 | 318,939,120 |
| Scope 2 | - |
| Scope 3 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
JOINTOWN PHARMACEUTICAL GROUP is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
